-Robert W Buckheit Researcher Activity Profile

Research Author Detailed Information 

Robert W Buckheit Publication Rate By Year

Robert W Buckheit has published 7 paper(s) in 2007, 3 paper(s) in 2008, for a total of 10 research publications in total.

Robert W Rw Buckheit Author Information

LAST NAME: buckheit

FIRST NAME: Robert W

INITIALS: rw

AFFILIATION:

Papers

Robert W Buckheit's Publication Record

1. Total synthesis of anibamine, a novel natural product as a chemokine receptor CCR5 antagonist. Year Published: 2007
Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23298-0540, USA.
2. Carrageenan/MIV-150 (PC-815), a combination microbicide. Year Published: 2007
Population Council, New York, NY, USA.
3. Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems. Year Published: 2007
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, USA.
4. Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability. Year Published: 2007
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Purdue University, West Lafayette, Indiana 47907, Imquest Biosciences, 7340 Executive Way, Suite R, Frederick, Maryland 21704, USA.
5. The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors. Year Published: 2007
ImQuest BioSciences, Inc., Frederick, MD, USA. rbuckheit@imquest.com
6. Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2. Year Published: 2007
ImQuest BioSciences, Inc., 7340 Executive Way, Suite R, Frederick, MD 21704. rbuckheit@imquest.com.
7. The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors. Year Published: 2007
ImQuest BioSciences, Inc., Frederick, MD, USA. rbuckheit@imquest.com
8. Inhibition of tubulin polymerization by select alkenyldiarylmethanes. Year Published: 2008
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and Purdue Cancer Center, Purdue University, West Lafayette, IN 47907, USA.
9. Inhibition of tubulin polymerization by select alkenyldiarylmethanes. Year Published: 2008
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and Purdue Cancer Center, Purdue University, West Lafayette, IN 47907, USA.
10. Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors. Year Published: 2008
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and the Purdue Cancer Center, Purdue University, West Lafayette, IN 47907, USA.